A novel video tracking method to evaluate the effect of influenza infection and antiviral treatment on ferret activity

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Oh, Ding Yuan ^a,b   Barr, Ian G ^a,b   Hurt, Aeron C ^a,c  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b UNIVERSITY OF BALLARAT   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; ANTIVIRUS AGENT;

ADULT; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL THERAPY; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FERRET; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H1N1 PDM09; MALE; METHODOLOGY; NONHUMAN; UPPER RESPIRATORY TRACT INFECTION; VIDEORECORDING; VIRUS SHEDDING; WEIGHT REDUCTION; ANIMAL; DRUG EFFECTS; INFLUENZA A VIRUS (H1N1); ORTHOMYXOVIRIDAE INFECTIONS; PHYSIOLOGY; VIROLOGY;

ANIMALIA; MUSTELA; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIVIRAL AGENTS; BEHAVIOR, ANIMAL; FEMALE; FERRETS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MALE; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR; VIDEO RECORDING;

EID: 84928902059     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118780     Document Type: Article

References (29)

1. Cox N, Subbarao K. Influenza. Lancet. 1999; 354:1277-82. PMID: 10520648
2. WHO/GIP. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2014. 2014.
3. WHO/HQ. Map and epidemiological curve of confirmed human cases of avian influenza A(H7N9). Periodical reports. 2014;18.
4. Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, Zeng H, et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science (New York, NY). 2009; 325(5939):484-7. doi: 10.1126/science.1177238 PMID: 19574347
5. Wong SS, Jeevan T, Kercher L, Yoon SW, Petkova AM, Crumpton JC, et al. A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets. Vaccine. 2014; 32(35):4571-7. doi: 10.1016/j.vaccine.2014.06.016 PMID: 24950355
6. Govorkova EA, Marathe BM, Prevost A, Rehg JE, Webster RG. Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets. Antiviral research. 2011; 91(2):81-8. doi: 10.1016/j.antiviral.2011.05.008 PMID: 21635924
7. Oh DY, Lowther S, McCaw JM, Sullivan SG, Leang SK, Haining J, et al. Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact. The Journal of antimicrobial chemotherapy. 2014; 69(9):2458-69. doi: 10.1093/jac/dku146 PMID: 24840623
8. Boltz DA, Rehg JE, McClaren J, Webster RG, Govorkova EA. Oseltamivir prophylactic regimens prevent H5N1 influenza morbidity and mortality in a ferret model. The Journal of infectious diseases. 2008; 197(9):1315-23. doi: 10.1086/586711 PMID: 18422444
9. Kim HM, Kang YM, Ku KB, Park EH, Yum J, Kim JC, et al. The severe pathogenicity of alveolar macrophage-depleted ferrets infected with 2009 pandemic H1N1 influenza virus. Virology. 2013; 444(1-2):394-403.
10. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 2009; 460(7258):1021-5. doi: 10.1038/nature08260 PMID: 19672242
11. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, Bestebroer TM, et al. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science (New York, NY). 2009; 325(5939):481-3. doi: 10.1126/science.1177127 PMID: 19574348
12. Govorkova EA, Ilyushina NA, Boltz DA, Douglas A, Yilmaz N, Webster RG. Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrobial agents and chemotherapy. 2007; 51(4):1414-24. PMID: 17296744
13. Zhang Q, Shi J, Deng G, Guo J, Zeng X, He X, et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science (New York, NY). 2013; 341(6144):410-4. doi: 10.1126/science.1240532 PMID: 23868922
14. Guarnaccia T, Carolan LA, Maurer-Stroh S, Lee RT, Job E, Reading PC, et al. Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model. PLoS pathogens. 2013; 9(5):e1003354. doi: 10.1371/journal.ppat.1003354 PMID: 23671418
15. Reuman PD, Keely S, Schiff GM. Assessment of signs of influenza illness in the ferret model. Journal of virological methods. 1989; 24(1-2):27-34. PMID: 2668319
16. Marriott AC, Dove BK, Whittaker CJ, Bruce C, Ryan KA, Bean TJ, et al. Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir. PloS one. 2014; 9(4):e94090. doi: 10.1371/journal.pone.0094090 PMID: 24709834
17. Stark GV, Long JP, Ortiz DI, Gainey M, Carper BA, Feng J, et al. Clinical profiles associated with influenza disease in the ferret model. PloS one. 2013; 8(3):e58337. doi: 10.1371/journal.pone.0058337 PMID: 23472182
18. Ilyushina NA, Seiler JP, Rehg JE, Webster RG, Govorkova EA. Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets. PLoS pathogens. 2010; 6(5):e1000933. doi: 10.1371/journal.ppat.1000933 PMID: 20523902
19. Long JP, Vela EM, Stark GV, Jones KJ, Miller ST, Bigger JE. Early indicators of disease in ferrets infected with a high dose of avian influenza H5N1. Scientific reports. 2012; 2:972. doi: 10.1038/srep00972 PMID: 23240077
20. Ben-Ami Bartal I, Rodgers DA, Bernardez Sarria MS, Decety J, Mason P. Pro-social behavior in rats is modulated by social experience. eLife. 2014; 3:e01385. doi: 10.7554/eLife.01385 PMID: 24424411
21. Duclot F, Kabbaj M. Individual differences in novelty seeking predict subsequent vulnerability to social defeat through a differential epigenetic regulation of brain-derived neurotrophic factor expression. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2013; 33(27):11048-60. doi: 10.1523/JNEUROSCI.0199-13.2013 PMID: 23825410
22. Horn CC, Meyers K, Pak D, Nagy A, Apfel CC, Williams BA. Post-anesthesia vomiting: impact of isoflurane and morphine on ferrets and musk shrews. Physiology & behavior. 2012; 106(4):562-8.
23. Dimmock NJ, Dove BK, Meng B, Scott PD, Taylor I, Cheung L, et al. Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir. Antiviral research. 2012; 96(3):376-85. doi: 10.1016/j.antiviral.2012.09.017 PMID: 23041142
24. Oh DY, Barr IG, Mosse JA, Laurie KL. MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells. Journal of clinical microbiology. 2008; 46(7):2189-94. doi: 10.1128/JCM.00398-08 PMID: 18480230
25. Monto AS, Maassab HF. Ether treatment of type B influenza virus antigen for the hemagglutination inhibition test. Journal of clinical microbiology. 1981; 13(1):54-7. PMID: 7462419
26. Rockman S, Brown LE, Barr IG, Gilbertson B, Lowther S, Kachurin A, et al. Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine. Journal of virology. 2013; 87(6):3053-61. doi: 10.1128/JVI.02434-12 PMID: 23283953
27. Pallister J, Middleton D, Wang LF, Klein R, Haining J, Robinson R, et al. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. Vaccine. 2011; 29(34):5623-30. doi: 10.1016/j.vaccine.2011.06.015 PMID: 21689706
28. Pallister JA, Klein R, Arkinstall R, Haining J, Long F, White JR, et al. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months. Virology journal. 2013; 10:237. doi: 10.1186/1743-422X-10-237 PMID: 23867060
29. Darnell ME, Plant EP, Watanabe H, Byrum R, St Claire M, Ward JM, et al. Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets. The Journal of infectious diseases. 2007; 196 (9):1329-38. PMID: 17922397